课题基金 / 基金详情

Synthetic Studies on Endothelin and Its Related Peptides Using a New S-Derotecting Reagent

Synthetic Studies on Endothelin and Its Related Peptides Using a New S-Derotecting Reagent
新型S-去保护试剂合成内皮素及其相关肽的研究
批准号:
01571149
负责人:
FUJII Nobutaka
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1989
资助国家:
日本
项目状态:
已结题
起止时间:
1989 至 1990

项目摘要

项目成果

FUJII Nobutaka的其他基金

相似基金

相关文献

中文摘要
翻译
内皮素(et -1)是一种21残基肽,由Yanagisawa等人从主动脉内皮细胞中发现,具有有效的血管收缩作用。对预内皮素cDNA的克隆和测序研究表明,存在ET-21的推定特异位点,命名为大内皮素(big ET),由38个氨基酸残基组成。此外,还发现了其他类型的ET,并将其命名为ET- ii和ET- iii。大ET可以通过一种独特的内肽酶“内皮素转换酶”(ECE)进一步加工成ET-21。为了评价ET的生理意义和阐明ECE的化学性质,我们采用两种固相法合成了ET (ETI,II,III,)人大ET及其相关肽。在本合成研究过程中,提出了一种新的脱保护试剂——三氟甲烷磺酸银,以及一种新的两步硬酸脱保护/解理工艺[1]。3 . sibr脱保护;开发了HF(或Me_3SiOSO_2CF_3)解理。利用自动合成器对ET-1进行了固相合成。作为氨基酸衍生物,采用了Cys(Acm)、Asp(OBzl)、Glu(OBzl)、Ser(Bzl)、Thr(Bzl)、Trp(CHO)、His(Tos)、Tyr(BrZ)、Lys(CIZ)和Arg(Mts)。在最后一步,我们成功地利用上述两种新方法获得了具有生物活性的ET-I。以基本相同的方法制备人大内皮素(ET-38)和et - 1的c端延长同源物ET-22、ET-23、ET-31和ET-36。et - ii和et - iii根据Sheppard等人的原理,利用s -对甲氧基苄基(MBzl)对4个Cys残基进行保护,采用基于fmoc的固相人工合成。在几种生物测定系统中对合成的ET、大ET及其相关肽进行了评价。人大ET的体外血管收缩活性比ET- 1低两个数量级。然而,在大鼠体内实验中,人大ET在累积给药后引起动脉压的剂量依赖性升高,其效力与ET- 1基本相同。c端长肽ET-22、ET-23、ET-31和ET-36的活性与人大ET相当。因此,大ET和所有c端长肽可能在动物体内被ECE直接加工成ET-21。少
英文摘要
Endothelin (ET-1), a 21-residue peptide, characterized from aortic endothelial cells by Yanagisawa, et al., has a potent vasoconstrictor effect. Studies on cloning and sequencing of prepro ET cDNA have revealed the existence of the putative pecuraor of ET-21, named big endothelin (big ET), consisting of 38 amino acid residues. In addition, other types of ET were found and named ET-II, and ET-III. Big ET could be further processed to ET-21 by a unique endopeptidase named "enodothelin converting enzyme" (ECE). In order to evaluate the physiological significance of ET and clarify the chemical nature of ECE, we have synthesized ETs (ETI,II,III,) human big ET and their related peptides by two alternative solid phase method. In the course of this synthetic studies, a new Sdeprotecting reagent, silver trifluoromethanesulphonate, and a new two step hard acid deprotection/cleavage procedure [1._3SiBr deprotection and 2. HF(or Me_3SiOSO_2CF_3) cleavage] were developed.Boc-based solid phase synth … More esis of ET-1 was carried out by using automatic synthesizer. As amino acid derivatives, Cys(Acm), Asp(OBzl), Glu(OBzl), Ser(Bzl), Thr(Bzl), Trp(CHO), His(Tos), Tyr(BrZ), Lys(CIZ), and Arg(Mts) were employed. In the final step, the above two new methods were successfully employed to give a biologically active ET-I. In essentially the same manner, human big endothelin (ET-38) and C-terminally elongated homologs of ET-I, such as ET-22, ET-23, ET-31, and ET-36 were prepared. ET-II and ET-III were synthesized manually by Fmoc-based solid phase synthesis according to the principle of Sheppard, et al., using S-p-methoxybenzyl (MBzl) protection for 4 Cys residues. ETs, big ET, and their related peptides thus synthesized were assessed to the several bioassay systems.The in vitro vasoconstrictor activity of human big ET was two orders of magnitude less than that of ET-I. However, in vivo assay in rats, human big ET caused a dose dependent rise of arterial pressure after the cumulative administration in essentially the same potency as that of ET-I. The activities of C-terminally elongated peptides, ET-22, ET-23, ET-31, and ET-36, were comparable to that human big ET. Thus, it was suggested that big-ET and all of C-terminally elongated peptides might be processed directly to ET-21 by ECE in animal body. Less
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Nobutaka Fujii他: "Silver Trifluoromethanesulfonate as an S-Deprotecting Reagent for the Synthesis of Cystine Peptide" J.Chem.Soc.,Chem.Commun.283-284 (1989)
Nobutaka Fujii 等人:“三氟甲磺酸银作为胱氨酸肽合成的 S-去保护试剂”J.Chem.Soc.,Chem.Commun.283-284 (1989)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Motoyoshi Nomizu, Yoshimasa Iagaki, Takeyoshi Yamashita, Ako Okubo, Akira Otaka, Nobutaka Fujii, Peter P. Roller, and Haruaki Yajima: "Two-Step Hard Acid Deprotection/Cleavage Procedure for Solid Phase Peptide Synthesis" Int. J. Peptide Protein Res.
Motoyoshi Nomizu、Yoshimasas Iagaki、Takeyoshi Yamashita、Ako Okubo、Akira Otaka、Nobutaka Fujii、Peter P. Roller 和 Haruaki Yajima:“固相肽合成的两步硬酸脱保护/裂解程序” Int。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hiroshi Morimoto: "Silver Trifluoromethanesulphonate,as an SーAcm Deprotecting Reagent and its Application to The Synthesis of Endothelin and EndothelinーLike Peptide" Peotide Chemistry. 211-214 (1989)
Hiroshi Morimoto:“三氟甲磺酸银,作为 S-Acm 脱保护试剂及其在内皮素和内皮素样肽合成中的应用”Peotide Chemistry 211-214 (1989)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Motoyoshi Nomizu: "Solid Phase Peptide Synthesis of Human Endothelin Precursor Peptides Using TwoーStep Hard Acid Deprotection/Cleavage Methods;" Int J.Peptide Protein Res.
Motoyoshi Nomizu:“使用两步硬酸脱保护/切割方法固相合成人内皮素前体肽;”Int J.Peptide Protein Res。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 7 条
    Development and application of a novel screening technolgy toward effective uses of chemical library
    • 批准号:
      24659046
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2012
    • 负责人:
      FUJII Nobutaka
    • 依托单位:
    Practical medicinal chemistry on the basis of protein chemistry, computational science and synthetic technologies for a variety of heterocycles
    • 批准号:
      23390025
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.9万
    • 财政年份:
      2011
    • 负责人:
      FUJII Nobutaka
    • 依托单位:
    Evolution of Drug Discovery Targeting for G-protein Coupled Receptors
    • 批准号:
      17209004
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $33.36万
    • 财政年份:
      2005
    • 负责人:
      FUJII Nobutaka
    • 依托单位:
    Genome/Proteome-lead Drug Discovery Based on Peptide/Protein Chemistry
    • 批准号:
      14207099
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $32.28万
    • 财政年份:
      2002
    • 负责人:
      FUJII Nobutaka
    • 依托单位:
    海外基金